[Effects of blockade of ionotropic glutamate receptors on the development of pentylenetetrazole kindling in mice].
Effects of mono- and dicationic derivatives of adamantane and phenylcyclohexyl on the petyleneterazole-induced (35 mg/kg i. p.) kindling were studied in the experiments on mice. Monocationic derivative of phenylcyclohexyl IEM-1921, effectively retarded the development of kindling beginning the dose 0.0001 microM/kg. Memantine: derivative of adamantane (derivative of adamatane) produced the same effect with 100-fold increased dose. Dicationic derivative ofphenylcyclohexyl: IEM-1925, is able to block equally the open channels of both NMDA and subtype of Ca-permeable AMPA receptors. Its effect on kindling differed markedly from selective NMDA antagonists (IEM-1921 and memantine) in more complicated dose-dependence. The retardation of kindling IEM-1925 was induced at 0.001 microM/kg. On the contrary, a 10-time lower dose: 0.0001 microM/kg, facilitated the development of kindling. The observed difference in the activity of selective NMDA antagonists and the drugs combining anti-NMDA and anti-AMPA potency indicates that both types of ionotropic glutamate receptors are involved in the mechanism of petyleneterazole-induced kindling. The integral effect of channel blockade evoked by drugs seems to be dependent not only upon the ratio of the receptor types but on the kinetics of drug action, too.
Lukomskaia
N Ia
NIa
Lavrent'eva
V V
VV
Starshinova
L A
LA
Zhabko
E P
EP
Gorbunova
L V
LV
Tikhonova
T B
TB
Gmiro
V E
VE
Magazanik
L G
LG
D000818:Animals; D003292:Convulsants; D003514:Cyclohexylamines / Q000008:administration & dosage / Q000494:pharmacology; D003959:Diamines / Q000008:administration & dosage / Q000494:pharmacology; D018691:Excitatory Amino Acid Antagonists / Q000008:administration & dosage / Q000494:pharmacology*; D007696:Kindling, Neurologic / Q000187:drug effects* / Q000502:physiology; D008297:Male; D008559:Memantine / Q000008:administration & dosage / Q000494:pharmacology; D051379:Mice; D010433:Pentylenetetrazole; D000644:Quaternary Ammonium Compounds / Q000008:administration & dosage / Q000494:pharmacology; D018091:Receptors, AMPA / Q000037:antagonists & inhibitors* / Q000502:physiology; D016194:Receptors, N-Methyl-D-Aspartate / Q000037:antagonists & inhibitors* / Q000502:physiology
D003292:Convulsants; D003514:Cyclohexylamines; D003959:Diamines; D018691:Excitatory Amino Acid Antagonists; C406748:IEM 1925; D000644:Quaternary Ammonium Compounds; D018091:Receptors, AMPA; D016194:Receptors, N-Methyl-D-Aspartate; C037320:1-phenylcyclohexylamine; D008559:Memantine; D010433:Pentylenetetrazole